BackBiomea Fusion Overview

Biomea Fusion Short-Term Investments

Biomea Fusion's short-term investments is $0.

Get informed when a big investor buys or sells

+ Follow
Short-Term Investments
$0.00

Peer trimmed avg / median

Loading

Biomea Fusion Short-Term Investments History

Loading

Biomea Fusion vs. peers: Short-Term Investments Comparison

Loading

Biomea Fusion Short-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biomea Fusion (BMEA) FAQ

As of the most recent data (June 2026), BMEA shows a short-term investments of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMEA's short-term investments is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Biomea Fusion is outperforming or lagging.

Tracking BMEA's short-term investments over time shows whether Biomea Fusion is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this short-term investments page, Stockcircle has Biomea Fusion's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect short-term investments (currently $0) with ownership activity and broader fundamentals.

Biomea Fusion's short-term investments is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.